32
Participants
Start Date
February 28, 2013
Primary Completion Date
December 31, 2016
Study Completion Date
July 31, 2017
Carfilzomib
IV over 30 minutes on Days 1, 2, 8, 9, 15, and 16 every 28 days.
Dexamethasone
Dexamethasone IV or PO on Days 1, 2, 8, 9, 15, and 16 every 28 days in patients with \<VGPR after 4 cycles.
Columbia University, New York
Memorial Sloan-Kettering Cancer Center, New York
Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Duke University Medical Center, Durham
Winship Cancer Institute of Emory University, Atlanta
City of Hope, Duarte
Stanford Cancer Institute, Stanford
Oregon Health and Sciences University, Portland
Boston University Medical Center, Boston
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Lead Sponsor
Collaborators (1)
Amgen
INDUSTRY
Criterium, Inc.
INDUSTRY